Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice

Arthritis and Rheumatism
M P ScolaA A Grom

Abstract

Although increased vascularity was noted in early histopathologic studies of juvenile rheumatoid arthritis (JRA) synovium, the available data on angiogenesis in JRA are very limited. The main purposes of this study were to assess expression of the key angiogenic factors in JRA synovium, and to evaluate a SCID mouse model of JRA as an approach to study in vivo regulation of the expression of these factors in JRA. RNase protection assay was used to assess the expression of the key angiogenic factors in fresh JRA synovium and in JRA synovial tissue fragments that had been minced and then implanted into SCID mice. Vascularity of the samples was assessed by immunohistochemical staining for von Willebrand factor. Synovial specimens obtained from patients with osteoarthritis (OA) or other noninflammatory arthropathies were used as controls. Detectable levels of messenger RNA for vascular endothelial growth factor and angiopoietin 1 and their respective receptors, as well as endoglin and thrombin receptors, were present in all JRA tissue specimens studied. The levels of expression of these factors in JRA tissues were significantly higher than those in tissues obtained from patients with OA or other noninflammatory arthropathies. Furthe...Continue Reading

References

Apr 1, 1992·The Journal of Experimental Medicine·D J PeacockE Brahn
May 3, 1990·The New England Journal of Medicine·E D Harris
Jan 1, 1987·Scandinavian Journal of Rheumatology. Supplement·T Egeland
Feb 1, 1986·Arthritis and Rheumatism·J T CassidyJ G Schaller
Jan 1, 1995·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·S HosakaA E Koch
Oct 1, 1996·British Journal of Rheumatology·E M Paleolog
Jun 17, 1998·Arthritis and Rheumatism·A E Koch
Oct 17, 1998·Science·C SuriG D Yancopoulos
Jan 12, 1999·The Journal of Clinical Investigation·G S Firestein
Jan 12, 1999·The Journal of Clinical Investigation·C M StorgardD A Cheresh
May 29, 1999·Science·D Y LiD P Wendel
Dec 22, 1999·International Journal of Experimental Pathology·S C BallaraE M Paleolog
May 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·C S ChoH Y Kim
Sep 23, 2000·Nature·G D YancopoulosJ Holash

❮ Previous
Next ❯

Citations

Oct 18, 2003·Joint, Bone, Spine : Revue Du Rhumatisme·Gaëlle ClavelMarie-Christophe Boissier
Aug 1, 2007·Nature Clinical Practice. Rheumatology·Dahlia Lainer-Carr, Ernest Brahn
Dec 28, 2010·Rheumatology·Ignazia PrigioneFabio Morandi
Jan 20, 2010·Archives of Medical Research·Sittisak HonsawekPongsak Yuktanandana
Oct 14, 2008·International Immunopharmacology·Antonio G Tristano
Mar 6, 2007·Lancet·Angelo Ravelli, Alberto Martini
Apr 19, 2002·Current Problems in Cancer·George W Sledge, Kathy D Miller
Jan 11, 2011·Korean journal of pediatrics·Youn-Soo Hahn, Joong-Gon Kim
Aug 23, 2005·The Journal of the American Academy of Orthopaedic Surgeons·Dane Glueck, Harris Gellman
Dec 7, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·Yuka KondoKeiji Nogami
Oct 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michel De BandtCatherine Pasquier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.